EGF-mediated Suppression of Cell Extrusion During Mucosal Damage Attenuates Opportunistic Fungal Invasion
Overview
Cell Biology
Molecular Biology
Authors
Affiliations
Severe and often fatal opportunistic fungal infections arise frequently following mucosal damage caused by trauma or cytotoxic chemotherapy. Interaction of fungal pathogens with epithelial cells that comprise mucosae is a key early event associated with invasion, and, therefore, enhancing epithelial defense mechanisms may mitigate infection. Here, we establish a model of mold and yeast infection mediated by inducible epithelial cell loss in larval zebrafish. Epithelial cell loss by extrusion promotes exposure of laminin associated with increased fungal attachment, invasion, and larval lethality, whereas fungi defective in adherence or filamentation have reduced virulence. Transcriptional profiling identifies significant upregulation of the epidermal growth factor receptor ligand epigen (EPGN) upon mucosal damage. Treatment with recombinant human EPGN suppresses epithelial cell extrusion, leading to reduced fungal invasion and significantly enhanced survival. These data support the concept of augmenting epithelial restorative capacity to attenuate pathogenic invasion of fungi associated with human disease.
Lengyel M, Ma Y, Gelashvili Z, Peng S, Quraishi M, Niethammer P bioRxiv. 2025; .
PMID: 39974905 PMC: 11839128. DOI: 10.1101/2025.02.05.636712.
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research.
Lewis R J Fungi (Basel). 2024; 10(6).
PMID: 38921367 PMC: 11205125. DOI: 10.3390/jof10060382.
From Spores to Solutions: A Comprehensive Narrative Review on Mucormycosis.
Gulli S, Hallur V, Kale P, Menezes G, Russo A, Singla N Diagnostics (Basel). 2024; 14(3).
PMID: 38337830 PMC: 10855476. DOI: 10.3390/diagnostics14030314.
Experimental Models to Study the Pathogenesis and Treatment of Mucormycosis.
Ben-Ami R J Fungi (Basel). 2024; 10(1).
PMID: 38276032 PMC: 10820959. DOI: 10.3390/jof10010085.
Mucormycosis in 2023: an update on pathogenesis and management.
Alqarihi A, Kontoyiannis D, Ibrahim A Front Cell Infect Microbiol. 2023; 13:1254919.
PMID: 37808914 PMC: 10552646. DOI: 10.3389/fcimb.2023.1254919.